Nirav Commercial (512425)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹604.95 |
| Market Cap | ₹24.96 Cr |
| P/E Ratio | 0 |
| ROCE | 0.75% |
| ROE | 0.03% |
| Dividend Yield | 0% |
| Profit Growth | -35.71% |
| Debt/Equity | — |
| Sales Growth | -57.02% |
| 52-Week Range | ₹551 — ₹953.3 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹755.13 |
Strengths
- Price of ₹604.95 is at a 20% discount to book value of ₹755.13 per share (P/B 0.80).
- Latest quarter sales of ₹2 crore show the company is still a going concern, not a dormant shell.
- ROE and ROCE are positive, albeit negligible at 0.03% and 0.75%, so book value is not being aggressively destroyed.
- Market cap of ₹25 crore against a larger book value provides a theoretical asset cushion.
Concerns
- Sales growth is deeply negative at -57.02%, and profit growth is -35.71%, indicating a shrinking business.
- Earnings power is essentially nil: P/E is 0.00, latest quarter net profit is ₹-0 crore, and dividend yield is 0.00%.
- Piotroski F-Score of 3/9 signals weak financial health and operational deterioration.
- Promoter holding is not disclosed, creating uncertainty about insider commitment and governance transparency.
AI Analysis
At ₹604.95, Nirav Commercial is a tiny ₹25 crore market cap trading at just 0.8 times book value of ₹755.13 per share. That looks like the kind of cigar-butt Benjamin Graham might examine. But the smoke is thin. The latest quarter shows sales of only ₹2 crore and net profit of essentially zero; over the trailing numbers, sales have collapsed by 57% and profits fell 36%. Return on equity is 0.03% and return on capital employed is 0.75%. In other words, this is not a business earning a return on the asset base; it is a business living off the residual value of its balance sheet. The Piotroski F-Score of 3 out of 9 reinforces the weak fundamental picture: poor profitability, deteriorating operations, and red flags on efficiency and asset quality. There is no dividend to compensate patient shareholders, and promoter holding is not disclosed, so I cannot judge whether insiders have skin in the game. As a value investor, I don't get excited by low P/B alone. Book value only matters if the assets are real, earning power exists, or management can unlock value through buybacks, dividends, or liquidation. None of that is visible here. The 52-week range ₹551 to ₹953 shows the stock has been volatile, and the lack of meaningful earnings makes valuation more a function of balance sheet than cash flows. This is a potential asset play, but a low-quality one. If the company can stabilise sales, improve ROE above return on savings, and start returning capital to shareholders, there may be a reason to stay. Until then, I would need a wide margin of safety beyond 20% discount to book, and evidence that the book value is not being eroded by continued losses. Price is what you pay; value is what you get. Here, the value is uncertain.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer